ESMO Real World Data and Digital Oncology

该指南仅针对写作过程，不涉及在研究过程中使用AI工具分析数据并从中得出见解；作者在写作过程中使用生成式人工智能（AI）及AI辅助技术时，只能用其改善可读性和语言，不得用其替代总结和解读数据、得出科学见解与结论或提出建议等任务，且使用该技术应在人类监督下进行。 模型中文摘要

The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. AI and AI-assisted technologies should not be used t…

所有作者均应对以下各项做出实质性贡献：（1）研究的设计与构思，或数据获取，或数据分析与解读；（2）撰写论文或对其进行重要的批判性修改；（3）对提交版本给予最终批准。 模型中文摘要

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

任何可能引起对所报告工作或所述结论、含义或意见产生偏倚疑问的财务利益或关联（直接或间接）或其他情况——包括作者个人或其所在部门或组织的相关商业或其他资金来源、个人关系或直接学术竞争——均应披露；潜在利益冲突的例子包括雇佣关系、咨询、持股、酬金、有偿专家证言、专利申请/注册以及资助等。 模型中文摘要

Any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition - should…

建议真实世界数据研究按照ESMO真实世界肿瘤学证据报告指南（GROW）进行报告；在稿件提交时，作者需提供GROW检查表并附流程图。 模型中文摘要

It is recommended that real-world data studies be reported according to the ESMO-Guidance for Reporting Oncology real-World evidence (GROW). At manuscript submission, authors are requested to provide the GROW checklist accompanied by a flowchart.

如果工作涉及人类受试者，作者应确保所描述的工作是按照世界医学协会《伦理准则》（赫尔辛基宣言）中涉及人类的实验规定进行的。 模型中文摘要

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.

文章被接受后，作者将被要求填写一份“许可协议”；开放获取文章允许的第三方再使用取决于作者选择的用户许可。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.

请访问开放获取页面以了解本期刊开放获取出版的更多信息。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

本期刊采用单盲同行评审流程；所有投稿将首先由编辑评估其是否适合该期刊，被认为合适的论文通常会送交至少两名独立专家评审员评估其科学质量；编辑负责对文章接受或拒绝做出最终决定，且编辑的决定是最终的。 模型中文摘要

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

预印本可以随时随地共享，符合Elsevier的共享政策；例如在预印本服务器上共享预印本不会被视为先行发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).